CN103494916B - Traditional Chinese medicine composition with effect of reducing blood sugar, as well as preparation method and application thereof - Google Patents
Traditional Chinese medicine composition with effect of reducing blood sugar, as well as preparation method and application thereof Download PDFInfo
- Publication number
- CN103494916B CN103494916B CN201310465427.4A CN201310465427A CN103494916B CN 103494916 B CN103494916 B CN 103494916B CN 201310465427 A CN201310465427 A CN 201310465427A CN 103494916 B CN103494916 B CN 103494916B
- Authority
- CN
- China
- Prior art keywords
- parts
- effect
- chinese medicine
- blood sugar
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 50
- 239000000203 mixture Substances 0.000 title claims abstract description 29
- 239000008280 blood Substances 0.000 title claims abstract description 24
- 210000004369 blood Anatomy 0.000 title claims abstract description 24
- 238000002360 preparation method Methods 0.000 title claims abstract description 20
- 230000000694 effects Effects 0.000 title claims abstract description 17
- 239000000463 material Substances 0.000 claims abstract description 31
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 22
- 239000007788 liquid Substances 0.000 claims abstract description 15
- 239000002775 capsule Substances 0.000 claims abstract description 12
- 239000008187 granular material Substances 0.000 claims abstract description 11
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims abstract description 8
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 8
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims abstract description 8
- 229940010454 licorice Drugs 0.000 claims abstract description 8
- 239000002994 raw material Substances 0.000 claims abstract description 7
- 239000002552 dosage form Substances 0.000 claims abstract description 3
- 238000001694 spray drying Methods 0.000 claims abstract description 3
- 240000004670 Glycyrrhiza echinata Species 0.000 claims abstract 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 39
- 239000000706 filtrate Substances 0.000 claims description 13
- 238000003756 stirring Methods 0.000 claims description 6
- 239000007921 spray Substances 0.000 claims description 5
- 239000003826 tablet Substances 0.000 claims description 5
- 239000002671 adjuvant Substances 0.000 claims description 3
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims 3
- 239000010135 fructus aurantii immaturus Substances 0.000 claims 3
- 210000000582 semen Anatomy 0.000 claims 3
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 claims 3
- 239000012567 medical material Substances 0.000 claims 2
- 238000005507 spraying Methods 0.000 claims 1
- 229940079593 drug Drugs 0.000 abstract description 17
- 230000002218 hypoglycaemic effect Effects 0.000 abstract description 16
- 244000025254 Cannabis sativa Species 0.000 abstract description 10
- 244000197580 Poria cocos Species 0.000 abstract description 7
- 235000008599 Poria cocos Nutrition 0.000 abstract description 7
- 241000251468 Actinopterygii Species 0.000 abstract description 6
- 244000144730 Amygdalus persica Species 0.000 abstract description 6
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 abstract description 6
- 244000183685 Citrus aurantium Species 0.000 abstract description 6
- 235000007716 Citrus aurantium Nutrition 0.000 abstract description 6
- 235000000228 Citrus myrtifolia Nutrition 0.000 abstract description 6
- 235000016646 Citrus taiwanica Nutrition 0.000 abstract description 6
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 abstract description 6
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract description 6
- 240000007890 Leonurus cardiaca Species 0.000 abstract description 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 238000009835 boiling Methods 0.000 abstract 1
- 238000012869 ethanol precipitation Methods 0.000 abstract 1
- 239000012141 concentrate Substances 0.000 description 10
- 241001465754 Metazoa Species 0.000 description 9
- 206010012601 diabetes mellitus Diseases 0.000 description 9
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 7
- 239000008103 glucose Substances 0.000 description 7
- 241000202807 Glycyrrhiza Species 0.000 description 6
- 241000699666 Mus <mouse, genus> Species 0.000 description 6
- 210000001508 eye Anatomy 0.000 description 6
- 201000001421 hyperglycemia Diseases 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 241000207925 Leonurus Species 0.000 description 4
- HIMXGTXNXJYFGB-UHFFFAOYSA-N alloxan Chemical compound O=C1NC(=O)C(=O)C(=O)N1 HIMXGTXNXJYFGB-UHFFFAOYSA-N 0.000 description 4
- 238000000889 atomisation Methods 0.000 description 4
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 3
- 239000003472 antidiabetic agent Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 235000007516 Chrysanthemum Nutrition 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 235000019260 propionic acid Nutrition 0.000 description 2
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 2
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 2
- 235000010234 sodium benzoate Nutrition 0.000 description 2
- 239000004299 sodium benzoate Substances 0.000 description 2
- 239000007779 soft material Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 241000208838 Asteraceae Species 0.000 description 1
- 229940123208 Biguanide Drugs 0.000 description 1
- 240000005250 Chrysanthemum indicum Species 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000220485 Fabaceae Species 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 244000202052 Poncirus trifoliata Species 0.000 description 1
- 235000000404 Poncirus trifoliata Nutrition 0.000 description 1
- 229940100389 Sulfonylurea Drugs 0.000 description 1
- 244000250129 Trigonella foenum graecum Species 0.000 description 1
- 235000001484 Trigonella foenum graecum Nutrition 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 150000004283 biguanides Chemical class 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000009693 chronic damage Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 229940000406 drug candidate Drugs 0.000 description 1
- -1 dry at 70-80°C Substances 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 239000003777 experimental drug Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 230000003345 hyperglycaemic effect Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 229940100688 oral solution Drugs 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000009495 sugar coating Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 235000001019 trigonella foenum-graecum Nutrition 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种具有降血糖功效的中药组合物,它所含的活性成分由下列重量份原料配比制备而成:大和红30-40份、益母草15-25份,桃仁8-12份、鱼眼草15-25份、枳实15-25份、茯苓15-25份和甘草8-12份,剂型是颗粒剂、片剂、口服液、胶囊剂,还公开了制备方法为加水煎煮,浓缩,醇沉,喷雾干燥,加入辅料,制成所需制剂,还公开了其在制备具有降血糖功效药物中的应用。The invention discloses a traditional Chinese medicine composition with the effect of lowering blood sugar. The active ingredients contained in the composition are prepared from the following raw materials in parts by weight: 30-40 parts of Yamato red, 15-25 parts of motherwort, and 8-12 parts of peach kernels , 15-25 parts of fish eye grass, 15-25 parts of citrus aurantium, 15-25 parts of poria cocos and 8-12 parts of licorice, the dosage forms are granules, tablets, oral liquid, capsules, and the preparation method is also disclosed as adding water to decoct Boiling, concentrating, ethanol precipitation, spray drying, adding auxiliary materials to prepare the required preparation, and also discloses its application in the preparation of drugs with hypoglycemic effect.
Description
技术领域 technical field
本发明涉及中药组合物,具体涉及一种具有降血糖功效的中药组合物及其制备方法和应用。 The invention relates to a traditional Chinese medicine composition, in particular to a traditional Chinese medicine composition with hypoglycemic effect and its preparation method and application.
背景技术 Background technique
糖尿病是一组以高血糖为特征的代谢性疾病。高血糖则是由于胰岛素分泌缺陷或其生物作用受损,或两者兼有引起。糖尿病时长期存在的高血糖,导致各种组织,特别是眼、肾、心脏、血管、神经的慢性损害、功能障碍。目前临床治疗2型的药物除胰岛素外,主要是口服降糖药,大致分为磺脲类、双胍类、中药制剂、其他降糖药及辅助用药。但是这些口服化学其副作用主要表现在对血相、肝功能、肾功能均有一定的损害作用,会引起患者糖尿病性心脑血管并发症,容易出现低血糖反应,对胃肠有刺激性,产生厌食、恶心、呕吐甚至腹泻等。因此选择高效而又可长期使用无任何毒副作用,疗效可靠,服用方便的降糖药物是急需的,中药对于治疗糖尿病有一定的疗效,对比西药具有疗效高、毒副作用小等特点,但目前的中药制剂治疗糖尿病的疗效并不显著,无法发挥中医治疗糖尿病的优势。 Diabetes is a group of metabolic diseases characterized by hyperglycemia. Hyperglycemia is caused by defective insulin secretion or impaired biological action, or both. The long-term high blood sugar in diabetes leads to chronic damage and dysfunction of various tissues, especially the eyes, kidneys, heart, blood vessels, and nerves. In addition to insulin, the current clinical treatment of type 2 drugs is mainly oral hypoglycemic drugs, which are roughly divided into sulfonylureas, biguanides, traditional Chinese medicine preparations, other hypoglycemic drugs and auxiliary drugs. However, the side effects of these oral chemicals are mainly manifested in the damage to the blood phase, liver function, and kidney function, which will cause diabetic cardiovascular and cerebrovascular complications, prone to hypoglycemia, irritating to the gastrointestinal tract, and producing anorexia , nausea, vomiting and even diarrhea. Therefore, it is urgent to choose high-efficiency and long-term use without any toxic and side effects, reliable curative effect, and convenient hypoglycemic drugs to take. Chinese medicine has certain curative effect for treating diabetes. The efficacy of traditional Chinese medicine preparations in treating diabetes is not significant, and the advantages of traditional Chinese medicine in treating diabetes cannot be brought into play.
发明内容 Contents of the invention
发明目的:为了解决上述问题,本发明的目的在于提供一种具有降血糖功效的中药组合物及其制备方法和应用。 Purpose of the invention: In order to solve the above problems, the purpose of the present invention is to provide a Chinese medicine composition with hypoglycemic effect and its preparation method and application.
技术方案:本发明的目的是通过如下的方案实现的: Technical scheme: the purpose of the present invention is achieved by the following scheme:
一种具有降血糖功效的中药组合物,由下列重量份原料药提取制备而成:大和红30-40份、益母草15-25份,桃仁8-12份、鱼眼草15-25份、枳实15-25份、茯苓15-25份和甘草8-12份。 A traditional Chinese medicine composition with hypoglycemic effect, which is prepared by extracting the following raw materials in parts by weight: 30-40 parts of Yamato red, 15-25 parts of motherwort, 8-12 parts of peach kernel, 15-25 parts of fish eye grass, citrus aurantium 15-25 parts of fenugreek, 15-25 parts of poria cocos and 8-12 parts of licorice.
上述一种具有降血糖功效的中药组合物,由下列重量份原料药提取制备而成:大和红35份、益母草20份,桃仁10份、鱼眼草20份、枳实20份、茯苓20份和甘草10份。 The above-mentioned traditional Chinese medicine composition with hypoglycemic effect is prepared by extracting the following raw materials in parts by weight: 35 parts of Yamato red, 20 parts of motherwort, 10 parts of peach kernel, 20 parts of fish eye grass, 20 parts of Citrus aurantium, and 20 parts of poria cocos And licorice 10 parts.
上述具有降血糖功效的中药组合物,剂型是颗粒剂、片剂、口服液、胶囊剂。 The dosage forms of the above-mentioned traditional Chinese medicine composition with hypoglycemic effect are granules, tablets, oral liquids, and capsules.
上述具有降血糖功效中药组合物的方法,制备步骤为:取大和红、益母草,桃仁、鱼眼草、枳实、茯苓和甘草药材合并,加水煎煮两次,合并煎液,浓缩至65℃时相对密度为1.10—1.20,加入乙醇,搅拌,使含醇量按体积百分比计算达65-85%,静置,过滤,滤液减压浓缩至65℃时相对密度为1.20-1.30并回收乙醇得浓缩液,将浓缩液加辅料制成口服液,或将浓缩液喷雾干燥,加入辅料,制成颗粒剂、片剂或胶囊剂。 The above method of the traditional Chinese medicine composition with hypoglycemic effect, the preparation steps are: take Yamato red, motherwort, peach kernel, fish eye grass, citrus aurantium, poria cocos and licorice medicinal materials, add water to decoct twice, combine the decoction, and concentrate to 65°C When the relative density is 1.10-1.20, add ethanol, stir, so that the alcohol content reaches 65-85% by volume percentage, stand still, filter, and the relative density of the filtrate is 1.20-1.30 when the filtrate is concentrated under reduced pressure to 65 ° C and recovers ethanol Concentrated liquid, the concentrated liquid is added with auxiliary materials to make oral liquid, or the concentrated liquid is spray-dried and added with auxiliary materials to make granules, tablets or capsules.
上述具有降血糖功效中药组合物的制备方法,煎煮条件为:第一次加水量为药材重量的8-12倍量,煎煮1-2h,第二次加水量为药材重量的6-10倍量,煎煮1-2h。 For the preparation method of the above-mentioned traditional Chinese medicine composition with hypoglycemic effect, the decocting conditions are as follows: the amount of water added for the first time is 8-12 times the weight of the medicinal materials, decocted for 1-2 hours, and the amount of water added for the second time is 6-10 times the weight of the medicinal materials. Double the amount, decoct for 1-2h.
上述具有降血糖功效中药组合物的制备方法,所述喷雾干燥条件为:进风温度为90-110℃,出风温度为80-90℃,物料温度为80-90℃,雾化压力为0.2-0.5兆帕,喷雾速度为1-10ml/s。 For the preparation method of the above-mentioned traditional Chinese medicine composition with hypoglycemic effect, the spray drying conditions are as follows: the inlet air temperature is 90-110°C, the outlet air temperature is 80-90°C, the material temperature is 80-90°C, and the atomization pressure is 0.2 -0.5MPa, the spray speed is 1-10ml/s.
上述具有降血糖功效的中药组合物在制备具有降血糖功效药物中的应用。 Application of the above-mentioned traditional Chinese medicine composition with hypoglycemic effect in the preparation of a drug with hypoglycemic effect.
有益效果: Beneficial effect:
1、从中医理论看,糖尿病中医认为是“消渴”证,伤寒论中将“消渴”这一病证列为厥阴病,方中大和红、益母草、桃仁活血、理气、止痛,共为君药,鱼眼草清热解毒,利湿、枳实行气化痰,共为臣药,茯苓健脾和胃,甘草调和诸药,共为佐使药,诸药相合,共奏活血化瘀、清热生津、祛痰之作用,用于糖尿病的治疗。 1. From the perspective of TCM theory, TCM considers diabetes as the syndrome of "diabetes", which is listed as Jueyin disease in Treatise on Febrile Diseases. As the monarch drug, the fish eye grass clears away heat and detoxifies, dampness-reducing, and trifoliate oranges promote qi and reduce phlegm. They are ministerial drugs together. Poria cocos invigorates the spleen and stomach, and licorice harmonizes other drugs. It is an adjuvant drug. , heat-clearing, promoting fluid, expectorant effect, for the treatment of diabetes.
2、本发明处方设计合理,配伍严谨。 2. The prescription design of the present invention is reasonable and the compatibility is strict.
3、本发明组成为天然中药材,无毒副作用,价格便宜。 3. The composition of the present invention is made of natural Chinese medicinal materials, has no toxic and side effects, and is cheap.
具体实施方式 Detailed ways
以下通过实施例形式,对本发明的上述内容再作进一步的详细说明,但不应将此理解为本发明上述主题的范围仅限于以下的实例,凡基于本发明上述内容所实现的技术均属于本发明的范围。 Below by embodiment form, above-mentioned content of the present invention is described in further detail again, but this should not be interpreted as the scope of the above-mentioned theme of the present invention being limited to following examples, all technologies realized based on the above-mentioned content of the present invention all belong to this invention the scope of the invention.
1、结合具体实施方式,对本发明进一步说明如下: 1, in conjunction with specific embodiment, the present invention is further described as follows:
按下表中所列重量配比称取本发明所需原料,单位:g The weight ratio listed in the table below takes the required raw materials of the present invention, unit: g
本发明中,大和红为豆科杭子梢属植物毛杭子梢,以根入药,鱼眼草为菊科植物小鱼眼草或菊叶鱼眼草的全草,其余均为药典品种。 In the present invention, Dahehong is Maohangzishao plant of the genus Fabaceae, and its root is used as medicine. Fisheye grass is the whole herb of Asteraceae small fisheye grass or Chrysanthemum chrysanthemum fisheye grass, and the rest are all pharmacopoeia varieties.
2.制备实施例 2. Preparation Example
以上表中原料配比为例,包括以下步骤: The ratio of raw materials in the above table is an example, including the following steps:
实施例1:颗粒剂的制备 Embodiment 1: the preparation of granule
按上表中各药材用量称取药材混合,加水煎煮两次,第一次加水为药材重量的8倍量,煎煮1.5h,第二次加水为药材重量的6倍量,煎煮1h,合并煎液,滤过,滤液浓缩至相对密度1.10(65℃),加适量乙醇使含醇量(体积分数)达65%,搅拌,静置24小时,滤过,滤液回收乙醇并浓缩至相对密度1.20(65℃)的浓缩液,经喷雾干燥(条件为进风温度为100℃,出风温度为80℃,物料温度为70℃,雾化压力为0.2兆帕,喷雾速度为5ml/s。),粉碎成干浸膏粉,再加入适当糊精,混合均匀,用适量80%乙醇润湿,制软材,过14目筛制粒,70℃干燥,60目整粒,得颗粒剂。 Weigh and mix the medicinal materials according to the amount of each medicinal material in the above table, add water to decoct twice, add water for the first time to 8 times the weight of the medicinal materials, decoct for 1.5 hours, add water for the second time to 6 times the weight of the medicinal materials, and decoct for 1 hour , combined decoction, filtered, the filtrate was concentrated to a relative density of 1.10 (65°C), added an appropriate amount of ethanol to make the alcohol content (volume fraction) reach 65%, stirred, left to stand for 24 hours, filtered, the filtrate recovered ethanol and concentrated to The concentrated solution with a relative density of 1.20 (65°C) is spray-dried (conditions are that the inlet air temperature is 100°C, the outlet air temperature is 80°C, the material temperature is 70°C, the atomization pressure is 0.2 MPa, and the spray speed is 5ml/ s.), crushed into dry extract powder, then add appropriate amount of dextrin, mix evenly, moisten with appropriate amount of 80% ethanol, make soft material, granulate through 14 mesh sieve, dry at 70°C, granulate with 60 mesh to obtain granules agent.
实施例2:片剂的制备 Embodiment 2: the preparation of tablet
按上表中各药材用量称取药材混合,加水煎煮两次,第次加水为药材重量的10倍量,煎煮2h,第二次加水为药材重量的8倍量,煎煮1h,合并煎液,滤过,滤液浓缩至相对密度1.15(65℃),加适量乙醇使含醇量(体积分数)达75%,搅拌,静置24小时,滤过,滤液回收乙醇并浓缩至相对密度1.25(65℃)的浓缩液,经喷雾干燥(条件为进风温度为120℃,出风温度为90℃,物料温度为80℃,雾化压力为0.3兆帕,喷雾速度为7.5/s。),粉碎成干浸膏粉,再加入适量糖粉,混合均匀,用适量80%乙醇润湿,制软材,过30目筛制粒,于70~80℃干燥,用60目筛整粒,压片,包糖衣,分装,外包装,送检合格,得成品。 Weigh and mix the medicinal materials according to the amount of each medicinal material in the above table, add water to decoct twice, add water for the first time to 10 times the weight of the medicinal materials, decoct for 2 hours, add water for the second time to 8 times the weight of the medicinal materials, decoct for 1 hour, and combine Decoction, filter, concentrate the filtrate to a relative density of 1.15 (65°C), add an appropriate amount of ethanol to make the alcohol content (volume fraction) reach 75%, stir, let stand for 24 hours, filter, recover ethanol from the filtrate and concentrate to a relative density 1.25 (65°C) concentrated solution, spray-dried (conditions are that the inlet air temperature is 120°C, the outlet air temperature is 90°C, the material temperature is 80°C, the atomization pressure is 0.3 MPa, and the spray speed is 7.5/s. ), crushed into dry extract powder, then add an appropriate amount of powdered sugar, mix well, moisten with an appropriate amount of 80% ethanol, make a soft material, pass through a 30-mesh sieve to granulate, dry at 70-80°C, and granulate with a 60-mesh sieve , tableting, sugar-coating, sub-packaging, outer packaging, and passing the inspection to obtain the finished product.
实施例3:口服液的制备 Embodiment 3: the preparation of oral liquid
按上表中各药材用量称取药材混合,加水煎煮两次,第一次加水为药材重量的12倍量,煎煮2h,第二次加水为药材重量的10倍量,煎煮2h,合并煎液,滤过,滤液浓缩至相对密度1.20(65℃),加适量乙醇使含醇量(体积分数)达85%,搅拌,静置24小时,滤过,滤液回收乙醇并浓缩至相对密度1.30(65℃)的浓缩液,加蔗糖和丙酸0.1%或者苯甲酸钠0.1%~0.25%等作为防腐剂,得口服液成品。 Weigh and mix the medicinal materials according to the amount of each medicinal material in the above table, add water to decoct twice, add water for the first time to 12 times the weight of the medicinal materials, decoct for 2 hours, add water for the second time to 10 times the weight of the medicinal materials, and decoct for 2 hours, Combine the decoctions, filter, concentrate the filtrate to a relative density of 1.20 (65°C), add an appropriate amount of ethanol to make the alcohol content (volume fraction) reach 85%, stir, let stand for 24 hours, filter, recover the ethanol from the filtrate and concentrate to a relative The concentrated solution with a density of 1.30 (65° C.) is added with sucrose and 0.1% propionic acid or 0.1% to 0.25% sodium benzoate as preservatives to obtain a finished oral solution.
实施例4:胶囊剂的制备 Embodiment 4: the preparation of capsule
按上表中各药材用量称取药材混合,加水煎煮两次,第一次加水为药材重量的10倍量,煎煮1.5h,第二次加水为药材重量的8倍量,煎煮1.5h,合并煎液,滤过,滤液浓缩至相对密度1.15(65℃),加适量乙醇使含醇量(体积分数)达75%,搅拌,静置24小时,滤过,滤液回收乙醇并浓缩至相对密度1.25(65℃)的浓缩液,经喷雾干燥(条件为进风温度为120℃,出风温度为90℃,物料温度为90℃,雾化压力为0.4兆帕,喷雾速度为7.5/s。),粉碎成干浸膏粉,过6号筛,再装入1号胶囊即可得成品。 Weigh and mix the medicinal materials according to the amount of each medicinal material in the above table, add water to decoct twice, add water for the first time to 10 times the weight of the medicinal materials, decoct for 1.5 hours, add water for the second time to 8 times the weight of the medicinal materials, and decoct for 1.5 hours h, combine the decoctions, filter, concentrate the filtrate to a relative density of 1.15 (65°C), add an appropriate amount of ethanol to make the alcohol content (volume fraction) reach 75%, stir, let stand for 24 hours, filter, recover the ethanol from the filtrate and concentrate Concentrate to a relative density of 1.25 (65°C), spray-dried (conditions are that the inlet air temperature is 120°C, the outlet air temperature is 90°C, the material temperature is 90°C, the atomization pressure is 0.4 MPa, and the spray speed is 7.5 / s.), crushed into dry extract powder, passed through a No. 6 sieve, and then filled into No. 1 capsule to obtain the finished product.
3.降低血糖的药效学研究 3. Pharmacodynamic study on lowering blood sugar
本发明的具有降低血糖作用中药组合物具有明显的降低血糖作用功效,以下用实验来 进一步说明本发明的效果: The Chinese medicine composition with hypoglycemic effect of the present invention has obvious hypoglycemic effect, further illustrates the effect of the present invention with experiment below:
实验动物:昆明种小鼠(20±2g)雄性,上海斯莱克实验动物有限公司提供,生产许可证:SCXK(沪)2007—0005。 Experimental animals: male Kunming mice (20±2g), provided by Shanghai Slack Experimental Animal Co., Ltd., production license: SCXK (Shanghai) 2007-0005.
实验药物:本中药组合物口服液,按上述口服液实施例方法制备。 Experimental drug: the oral liquid of this Chinese medicine composition was prepared according to the method of the above-mentioned oral liquid embodiment.
称取药材大和红35g、益母草20g,桃仁10g、鱼眼草20g、枳实20g、茯苓20g和甘草10g混合,加水煎煮两次,第一次加水为药材重量的12倍量,煎煮2h,第二次加水为药材重量的10倍量,煎煮2h,合并煎液,滤过,滤液浓缩至相对密度1.20(65℃),加适量乙醇使含醇量(体积分数)达85%,搅拌,静置24小时,滤过,滤液回收乙醇并浓缩至相对密度1.30(65℃)的浓缩液,加蔗糖和丙酸0.1%或者苯甲酸钠0.1%~0.25%等作为防腐剂,得口服液成品10支,规格:10mL/支(相当于含生药13.5g),批号:20120815。消渴丸,广州中一药业有限公司产品,批号20120410,规格为30g/瓶,每瓶120粒,10粒为2.5g。给药剂量:按照《人和动物间按体表面折算的等效剂量比值表》,每日70公斤人的用量为67.5g,每日每只20g小鼠的用量为67.5*0.0026=0.1755g,因每支口服液10mL含生药量为13.5g,即每只小鼠的用量为0.13ml,因此确定小剂量每只灌胃0.1ml口服液,中剂量和高剂量分别灌胃0.2ml和0.4mL,每日每只20g小鼠灌胃的口服液含生药量分别为0.135g,0.27g,0.54g,则按小鼠体重计,低剂量、中剂量和高剂量分别为6.75g生药量/kg、13.5g生药量/kg和27g生药量/kg。 Weigh 35g of medicinal materials Dahehong, 20g of motherwort, 10g of peach kernel, 20g of fisheye grass, 20g of Citrus aurantium, 20g of poria cocos and 10g of licorice, mix them, add water to decoct twice, add water for the first time to 12 times the weight of the medicinal materials, and decoct for 2 hours , add water for the second time to 10 times the weight of the medicinal material, decoct for 2 hours, combine the decoction, filter, and concentrate the filtrate to a relative density of 1.20 (65°C), add an appropriate amount of ethanol to make the alcohol content (volume fraction) reach 85%, Stir, stand still for 24 hours, filter, recover ethanol from the filtrate and concentrate to a concentrated solution with a relative density of 1.30 (65°C), add sucrose and 0.1% propionic acid or 0.1% to 0.25% sodium benzoate as preservatives, and obtain oral liquid 10 sticks of finished product, specification: 10mL/stick (equivalent to 13.5g of crude drug), batch number: 20120815. Xiaoke Wan, a product of Guangzhou Zhongyi Pharmaceutical Co., Ltd., batch number 20120410, the specification is 30g/bottle, 120 capsules per bottle, 10 capsules is 2.5g. Dosage: According to the "Equivalent Dose Ratio Table Between Humans and Animals Converted According to Body Surface", the daily dosage for a 70 kg person is 67.5g, and the daily dosage for each 20g mouse is 67.5*0.0026=0.1755g, Because each 10mL of oral liquid contains 13.5g of crude drug, that is, the dosage of each mouse is 0.13ml, so it is determined that the small dose is 0.1ml oral liquid, and the middle dose and high dose are 0.2ml and 0.4mL respectively. , the amount of crude drug contained in the oral liquid administered to each 20g mouse per day is 0.135g, 0.27g, and 0.54g, respectively, based on the weight of the mouse, the low dose, medium dose, and high dose are respectively 6.75g crude drug amount/kg , 13.5g crude drug amount/kg and 27g crude drug amount/kg.
阳性药消渴丸,广州中一药业有限公司产品,批号20120310,规格为30g/瓶,每瓶120粒,10粒为2.5g,病人使用一般每次10粒,每日2次,即人日用量5g,相当于每只20g小鼠用量为5*0.0026=0.013g,按每公斤小鼠算,即阳性药组给予消渴丸0.65g/kg。 Positive drug Xiaoke pill, product of Guangzhou Zhongyi Pharmaceutical Co., Ltd., batch number 20120310, specification 30g/bottle, 120 capsules per bottle, 10 capsules is 2.5g, patients generally use 10 capsules each time, twice a day, that is, people The daily dose is 5g, which is equivalent to 5*0.0026=0.013g per 20g mouse, calculated per kilogram of mice, that is, the positive drug group is given Xiaoke Wan 0.65g/kg.
仪器与试剂:四氧嘧啶(C4H2N2O4·H2O,分子量160.08),血糖仪、全自动生化仪、721分光光度计、酶标仪、天平。 Instruments and reagents: Alloxan (C 4 H 2 N 2 O 4 ·H 2 O, molecular weight 160.08), blood glucose meter, automatic biochemical analyzer, 721 spectrophotometer, microplate reader, balance.
适应性饲养1天后,随机取10只小鼠作为正常组,另90只动物禁食3-5小时,测空腹血糖,作为该批次动物基础血糖值。随后动物禁食24小时(自由饮水),腹腔注射四氧嘧啶(用前新鲜配制)130mg/kg造模,5天后动物禁食5小时,测血糖,血糖值10~25mmol/L为高血糖模型成功动物。 After one day of adaptive feeding, 10 mice were randomly selected as the normal group, and the other 90 animals were fasted for 3-5 hours, and the fasting blood glucose was measured as the basal blood glucose value of the batch of animals. Then the animals were fasted for 24 hours (free drinking water), intraperitoneally injected with alloxan (freshly prepared before use) 130mg/kg to build a model, and after 5 days, the animals were fasted for 5 hours, and their blood sugar was measured. A blood sugar value of 10-25mmol/L was a hyperglycemia model. success animal.
选高血糖模型动物40只,按禁食3-5小时的血糖水平分组,随机选1个模型对照组和4个剂量组(组间差不大于1.1mmol/L),每组10只动物,剂量组给予不同浓度受试样品,模型对照组给予溶剂,连续30天,测空腹血糖值(禁食同实验前),比较各组动物血糖值及血糖下降百分率。 Select 40 hyperglycemia model animals, group them according to the blood glucose level after fasting for 3-5 hours, randomly select 1 model control group and 4 dosage groups (the difference between the groups is not more than 1.1mmol/L), 10 animals in each group, The dose group was given different concentrations of test samples, and the model control group was given solvent. For 30 consecutive days, the fasting blood glucose was measured (fasting was the same as before the experiment), and the blood glucose and blood glucose reduction percentages of animals in each group were compared.
本发明对高糖模型小鼠血糖下降的作用((X士D) Effect ((X ± D) of the present invention on hyperglycemia model mouse blood sugar drop
与正常组比较***p<0.001,与模型组比较###p<0.001,与阳性药组比较¥p<0.05。 Compared with the normal group ***p<0.001, compared with the model group ###p<0.001, compared with the positive drug group ¥ p<0.05.
本发明药物对高血糖小鼠具有降糖效果,与模型组比较实验后血糖值显著降低,说明本发明具有降糖效果。本发明药物的高剂量组与阳性药组相比,血糖下降有显著性差异,说明本发明药物的效果优于阳性药。 The medicament of the present invention has hypoglycemic effect on hyperglycemic mice, and compared with the model group, the blood sugar level significantly decreases after the experiment, indicating that the present invention has hypoglycemic effect. Compared with the positive medicine group, the high-dose group of the medicine of the present invention has a significant difference in blood sugar drop, indicating that the effect of the medicine of the present invention is better than that of the positive medicine.
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310465427.4A CN103494916B (en) | 2013-10-09 | 2013-10-09 | Traditional Chinese medicine composition with effect of reducing blood sugar, as well as preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310465427.4A CN103494916B (en) | 2013-10-09 | 2013-10-09 | Traditional Chinese medicine composition with effect of reducing blood sugar, as well as preparation method and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103494916A CN103494916A (en) | 2014-01-08 |
CN103494916B true CN103494916B (en) | 2015-04-22 |
Family
ID=49860239
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310465427.4A Expired - Fee Related CN103494916B (en) | 2013-10-09 | 2013-10-09 | Traditional Chinese medicine composition with effect of reducing blood sugar, as well as preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103494916B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104146255B (en) * | 2014-08-18 | 2016-02-24 | 于法周 | A kind ofly be applicable to chewable tablets of type II diabetes people and preparation method thereof |
CN104800758A (en) * | 2015-04-30 | 2015-07-29 | 淄博齐鼎立专利信息咨询有限公司 | Traditional Chinese medicine for reducing blood glucose |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101642547A (en) * | 2009-06-14 | 2010-02-10 | 李承平 | Chinese patent medicine for treating diabetes |
CN101715850A (en) * | 2009-11-13 | 2010-06-02 | 中国绿色食品实业有限公司 | Health-preserving tea capable of preventing and treating diabetes mellitus and preparation method thereof |
CN102047997A (en) * | 2009-11-10 | 2011-05-11 | 上海市新文达生物科技有限公司 | Wuyi Mountain rock tea extract, and preparation method and application thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101195109B1 (en) * | 2009-08-20 | 2012-10-29 | 화 례 임 | composition of health food |
-
2013
- 2013-10-09 CN CN201310465427.4A patent/CN103494916B/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101642547A (en) * | 2009-06-14 | 2010-02-10 | 李承平 | Chinese patent medicine for treating diabetes |
CN102047997A (en) * | 2009-11-10 | 2011-05-11 | 上海市新文达生物科技有限公司 | Wuyi Mountain rock tea extract, and preparation method and application thereof |
CN101715850A (en) * | 2009-11-13 | 2010-06-02 | 中国绿色食品实业有限公司 | Health-preserving tea capable of preventing and treating diabetes mellitus and preparation method thereof |
Non-Patent Citations (2)
Title |
---|
崔同寅.锈钉子.《全国重名易混中药鉴别手册》.中国医药科技出版社,1992,(第1版),第87页. * |
胃肠舒治疗糖尿病性胃轻瘫的临床观察;钟毅等;《中国中西医结合杂志》;20050331;第25 卷(第03期);第87页 * |
Also Published As
Publication number | Publication date |
---|---|
CN103494916A (en) | 2014-01-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112972547A (en) | Traditional Chinese medicine composition for treating qi-blood deficiency syndrome and preparation method and application thereof | |
CN102271698B (en) | Pharmaceutical composition and use for preparing medicament thereof | |
CN104435749A (en) | Dendrobium officinale compound preparation as well as preparation method and application of dendrobium officinale compound preparation | |
CN1843452A (en) | Plaster for relieving asthma and stopping cough and its preparation method | |
CN102614281B (en) | Chinese medicinal composition for improving anoxia endurance and preparation method and application thereof | |
CN101856405A (en) | A kind of pharmaceutical composition for treating type 2 diabetes and its preparation method | |
CN103494916B (en) | Traditional Chinese medicine composition with effect of reducing blood sugar, as well as preparation method and application thereof | |
CN103494894B (en) | A kind of have Chinese medicine composition reducing blood glucose effect and its preparation method and application | |
CN101700275A (en) | A medicinal preparation containing jujube and its preparation method and application | |
CN107961272B (en) | Traditional Chinese medicine composition for treating chronic kidney diseases | |
CN103599343B (en) | A kind of pharmaceutical composition for the treatment of diabetes and its production and use | |
CN103919845B (en) | A kind of pharmaceutical composition for improving anoxia endurance and its preparation method and application | |
CN103127437A (en) | Traditional Chinese medicine composition having hypoglycemic effect | |
CN102715502B (en) | Preparation method of health food with function of anti-diabetes | |
CN102631498B (en) | Chinese medicine composition | |
CN113398185A (en) | Moisture-proof five-flavor disinfection beverage granules and preparation method thereof | |
CN1799582A (en) | Blood sugar- and blood pressure-lowering medicine | |
CN103989940A (en) | Traditional Chinese medicine composition for treating diabetes mellitus | |
CN103919972B (en) | A kind of pharmaceutical composition of resisting fatigue and its preparation method and application | |
CN101637573B (en) | Medicinal composition for treating diabetes and preparation method thereof | |
CN103751692B (en) | Special invigorating capsule of a kind of Testis et penis callorhini and preparation method thereof | |
CN102669660B (en) | Health-care food with antidiabetic effect | |
CN101744989B (en) | Method for extracting schisandra chinensis, ginseng and dwarf lilyturf root and preparation thereof | |
CN1686424A (en) | Medicinal composition containing scutellaria and bupleurum and its preparation method | |
CN107753551B (en) | Composition with function of reducing blood pressure and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150422 Termination date: 20171009 |
|
CF01 | Termination of patent right due to non-payment of annual fee |